Testicular implants.

Y Lakshmanan; S G Docimo

Home/Archive/PubMed

PubMed · 10173039

Testicular implants.

Y Lakshmanan·S G Docimo

View original source ↗Export metadata ↓

Abstract

Testicular implants have been in use for more than 50 years with an excellent record of safety and efficacy. The controversy concerning the use of silicone prosthetics in breast implants also affected testicular implants. There is no conclusive evidence associating connective tissue disorders, autoimmunity, or malignancy with silicone implants. Studies show silicone leakage from these implants, but long-term follow-up is required to identify the significance of this finding. Saline-filled silastic shell testicular prostheses will be implanted as part of an ongoing study to monitor various safety parameters, as required by the Food and Drug Administration.

Explore related subjects

Biocompatible Materials Dimethylpolysiloxanes Humans Male Prostheses and Implants Silicones Testis Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Y Lakshmanan, S G Docimo. 1997. Testicular implants.. https://pubmed.ncbi.nlm.nih.gov/10173039/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Effect of counterface roughness on the wear of conventional and crosslinked ultrahigh molecular weight polyethylene studied with a multi-directional motion pin-on-disk device.

The effect of counterface roughness on the wear of conventional gamma-sterilized, and electron-beam-crosslinked ultrahigh molecular weight polyethylene was studied with a circularly translating pin-on-disk device. The counterfaces, CoCr disks, were either polished, or roughened so that they represented the type of roughening and the range of surface roughness values (R(a) = 0.014-0.24 microm) observed in explanted femoral heads of total hip prostheses. The lubricant was diluted calf serum, and the test length 3 million cycles. A total of 24 tests were done. With both types of polyethylene, there was a strong correlation between R(a) and wear factor k. The power equations were k = 5.87 x 10(-5)(R(a))(0.91) for conventional polyethylene (R(2) = 0.94), and k = 7.87 x 10(-5)(R(a))(2.49) for crosslinked polyethylene (R(2) = 0.82). Crosslinking improved wear resistance significantly. The wear of crosslinked polyethylene against the roughest counterfaces was lower than the wear of conventional polyethylene against the polished counterfaces. Against rough counterfaces, the wear of crosslinked polyethylene was an order of magnitude lower than that of conventional polyethylene. On the crosslinked polyethylene pins that were tested against polished counterfaces, remains of original machining marks were still visible after the test. The average size of wear particles produced by both types of polyethylene against rough counterfaces was similar, 0.4 microm, whereas that produced by conventional and crosslinked polyethylene against polished counterfaces was significantly smaller, 0.2 and 0.1 microm, respectively.

Biocompatible Materials↗

PubMed2001

Sintering temperature effects on the in vitro bioactive response of tape cast and sintered bioactive glass-ceramic in Tris buffer.

Tape casting procedures were used to form thin polymeric sheets (100 microm thickness) loaded with bioactive glass particulate. Blanks were punched from the sheets, stacked, laminated, and heated in air to 500 degrees C to remove the organic phase. The resulting bioactive glass discs were sintered at 800 degrees C, 900 degrees C, or 1000 degrees C. Because the material is built up in layers and can be machined in the green state, such a processing technique can be used to form complex-shaped materials. The in vitro bioactivity of the tape cast sintered (TCS) bioactive glass-ceramic discs was then assessed in Tris buffer. The sample surface area to volume buffer (SA/V) ratio was approximately 0.1 cm(2)/mL. Tape cast bioactive glass-ceramic sintered at 900 degrees C and 1000 degrees C formed crystalline hydroxyapatite layers after 24 h in Tris buffer as indicated by FTIR, SEM, and EDS analysis. Decreasing the SA/V ratio to 0.013 cm(2)/mL allowed for the formation of crystalline hydroxyapatite layers on the surface of 800C TCS bioactive glass-ceramic. Given the dependence of the bioactive response as a function of the processing schedule and SA/V ratio, it may be possible to tailor the response to that desired in vivo or in vitro for tissue engineering studies. Biaxial flexural strength of TCS bioactive glass-ceramic increased with increasing sintering temperature. Strength of samples sintered at 1000 degrees C for 3 h increased from 87 to 120 MPa after 2 weeks' immersion in Tris buffer.

Biocompatible Materials↗

PubMed2001

Preparation and analysis of macroporous TiO2 films on Ti surfaces for bone-tissue implants.

This article describes the preparation and analysis of macroporous TiO2 films on Ti surfaces, for application in bone tissue-Ti implant interfaces. These TiO2 bioceramic films have a macroporous structure consisting of monodisperse, three-dimensional, spherical, interconnected pores adjustable in the micron size range. Micron-sized polystyrene (PS) bead templates are used to precisely define the pore size, creating macroporous TiO2 films with 0.50, 16, and 50 microm diameter pores, as shown by scanning electron microscopy. X-ray photoelectron spectroscopy shows the films to be predominantly composed of TiO2, with approximately 10% carbon. X-ray diffraction reveal rutile as the main phase when fired to the optimal temperature of 950 degrees C. Preliminary experiments find that the in vitro proliferation of human bone-derived cells (HBDC) is similar on all three pore sizes. However, higher [3H]thymidine incorporation by the HBDC is observed when they are grown on 0.50- and 16-microm pores compared to the 50-microm pores, suggesting an enhanced cell proliferation for the smaller pores.

Biocompatible Materials↗